Mira Pharmaceuticals (MIRA) Interest & Investment Income (2024 - 2025)
Mira Pharmaceuticals (MIRA) posted Interest & Investment Income of $8495.0 for Q2 2025, down 78.44% sequentially from $39397.0 in Q2 2024, and down 78.44% YoY from $39397.0 in Q2 2024.
Mira Pharmaceuticals (MIRA) Interest & Investment Income (2024 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 2 years of Interest & Investment Income data on file, last reported at $8495.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 229.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -645.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 73.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8,495.00 |
| Jun 30, 2024 | 39,397.00 |